P

Inventor

MCMAHON GERALD

US68 patents
⚠️ This page may combine multiple inventors who share the name “MCMAHON GERALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SUGEN INC

46 patents
US6133305AOct 17, 2000

3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity

SUGEN INC125 citations99
US5886020AMar 23, 1999

3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease

SUGEN INC376 citations99
US5883113AMar 16, 1999

3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease

SUGEN INC373 citations99
US5883116AMar 16, 1999

3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease

SUGEN INC180 citations99
US5880141AMar 9, 1999

Benzylidene-Z-indoline compounds for the treatment of disease

SUGEN INC106 citations99
US5834504ANov 10, 1998

3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease

SUGEN INC358 citations99
US5792783AAug 11, 1998

3-heteroaryl-2-indolinone compounds for the treatment of disease

SUGEN INC589 citations99
US5650415AJul 22, 1997

Quinoline compounds

SUGEN INC235 citations99
US6506763B2Jan 14, 2003

3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity

SUGEN INC76 citations98
US6395734B1May 28, 2002

Pyrrole substituted 2-indolinone protein kinase inhibitors

SUGEN INC79 citations98
US5773459AJun 30, 1998

Urea- and thiourea-type compounds

SUGEN INC117 citations98
US6696448B2Feb 24, 2004

3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors

SUGEN INC65 citations96
US6683082B2Jan 27, 2004

Bicyclic protein kinase inhibitors

SUGEN INC60 citations96
US6610688B2Aug 26, 2003

4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors

SUGEN INC74 citations96
US6486185B1Nov 26, 2002

3-heteroarylidene-2-indolinone protein kinase inhibitors

SUGEN INC64 citations96
US6316635B1Nov 13, 2001

2-indolinone derivatives as modulators of protein kinase activity

SUGEN INC87 citations96
US6239161B1May 29, 2001

Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions

SUGEN INC54 citations96
US6225346B1May 1, 2001

Tyrphostin like compounds

SUGEN INC61 citations96
US6143765ANov 7, 2000

Pharmaceutical compositions and methods for modulating signal transduction

SUGEN INC44 citations96
US6103728AAug 15, 2000

Quinazolines

SUGEN INC58 citations96
US5935993AAug 10, 1999

Tyrphostin like compounds

SUGEN INC72 citations96
US5891917AApr 6, 1999

Certain acrylonitrile-sulfonamide derivatives

SUGEN INC75 citations96
US5763470AJun 9, 1998

Benzopyran compounds and methods for their use

SUGEN INC57 citations96
US6204267B1Mar 20, 2001

Methods of modulating serine/thereonine protein kinase function with quinazoline-based compounds

SUGEN INC61 citations95
US5602171AFeb 11, 1997

Methods of inhibiting phosphatase activity and treatment of disorders associated therewith using naphthopyrones and derivatives thereof

SUGEN INC54 citations95
US7119090B2Oct 10, 2006

Pyrrole substituted 2-indolinone protein kinase inhibitors

SUGEN INC18 citations93
US6849641B1Feb 1, 2005

Azaindole tyrosine kinase inhibitors

SUGEN INC38 citations93
US6329375B1Dec 11, 2001

Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors

SUGEN INC27 citations93
US6316429B1Nov 13, 2001

Bicyclic protein kinase inhibitors

SUGEN INC19 citations93
US6225335B1May 1, 2001

3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease

SUGEN INC21 citations93
US6051593AApr 18, 2000

3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors

SUGEN INC17 citations93
US6004967ADec 21, 1999

Psoriasis treatment with quinazoline compounds

SUGEN INC74 citations93
US5883110AMar 16, 1999

Pharmaceutical compositions and methods for modulating signal transduction

SUGEN INC31 citations93
US6911446B2Jun 28, 2005

Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds

SUGEN INC37 citations92
US6689806B1Feb 10, 2004

Indolinone compounds as kinase inhibitors

SUGEN INC29 citations92
US6147106ANov 14, 2000

Indolinone combinatorial libraries and related products and methods for the treatment of disease

SUGEN INC37 citations92
US6114371ASep 5, 2000

3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors

SUGEN INC38 citations92
US5886195AMar 23, 1999

Thienyl compounds for inhibition of cell proliferative disorders

SUGEN INC34 citations92
US5780496AJul 14, 1998

Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions

SUGEN INC24 citations92
US5710173AJan 20, 1998

Thienyl compounds for inhibition of cell proliferative disorders

SUGEN INC34 citations92
US5614642AMar 25, 1997

Methods of inhibiting phosphatase activity and treatment of disorders associated therewith using naphthopyrones and derivatives thereof

SUGEN INC35 citations92
US6660763B2Dec 9, 2003

Bis-indolylquinone compounds

SUGEN INC20 citations91
US7211600B2May 1, 2007

Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds

SUGEN INC49 citations90
US6596772B1Jul 22, 2003

Phosphate mimics and methods of treatment using phosphatase inhibitors

SUGEN INC53 citations88
US6130238AOct 10, 2000

3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors

SUGEN INC18 citations84
US5798374AAug 25, 1998

Methods of inhibiting phosphatase activity and treatment of disorders associated therewith

SUGEN INC14 citations82

ASTA MEDICA AG

2 patents

ZENTARIS GMBH

1 patent

(unassigned)

1 patent

Showing the top 50 of 68 patents by PatentIndex Score.